Bone mineral density assessment in children with inflammatory bowel disease.

[1]  J. Chow,et al.  Colitis causes bone loss in rats through suppression of bone formation. , 1996, Gastroenterology.

[2]  C. Bernstein,et al.  A randomized, placebo‐controlled trial of calcium supplementation for decreased bone density in corticosteroid‐using patients with inflammatory bowel disease: a pilot study , 1996, Alimentary pharmacology & therapeutics.

[3]  Y. Koishihara,et al.  Endogenous bone‐resorbing factors in estrogen deficiency: Cooperative effects of IL‐1 and IL‐6 , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  A. Hergenroeder.  Bone mineralization, hypothalamic amenorrhea, and sex steroid therapy in female adolescents and young adults. , 1995, The Journal of pediatrics.

[5]  R. Jilka,et al.  Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. , 1995, The New England journal of medicine.

[6]  M. Dougados,et al.  Metabolic bone assessment in patients with inflammatory bowel disease. , 1995, Gastroenterology.

[7]  J. Sayre,et al.  Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  S. Manolagas.  Bone marrow, cytokines, and bone remodeling , 1995 .

[9]  R. Ziegler,et al.  Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis). , 2009, Experimental and clinical endocrinology.

[10]  W. Hannan,et al.  Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. , 1994, Gastroenterology.

[11]  S L Hui,et al.  Influences on skeletal mineralization in children and adolescents: evidence for varying effects of sexual maturation and physical activity. , 1994, The Journal of pediatrics.

[12]  R. Sartor,et al.  Cytokines in intestinal inflammation: pathophysiological and clinical considerations. , 1994, Gastroenterology.

[13]  D. Eyre,et al.  Bone resorption rates in children monitored by the urinary assay of collagen type I cross-linked peptides. , 1994, Bone.

[14]  G. Dalsky,et al.  Predictors of axial and peripheral bone mineral density in healthy children and adolescents, with special attention to the role of puberty. , 1993, The Journal of pediatrics.

[15]  S. Atkinson,et al.  Longitudinal Assessment of Growth, Mineral Metabolism, and Bone Mass in Pediatric Crohn's Disease , 1993, Journal of pediatric gastroenterology and nutrition.

[16]  K. Motil,et al.  Growth failure in children with inflammatory bowel disease: a prospective study. , 1993, Gastroenterology.

[17]  J. Landis,et al.  Calcium supplementation and bone mineral density in adolescent girls. , 1993, JAMA.

[18]  D. Eyre,et al.  A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross‐linked N‐telopeptides in urine , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  R. Rizzoli,et al.  Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. , 1992, The Journal of clinical endocrinology and metabolism.

[20]  H. Hodgson,et al.  Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease. , 1992, Gut.

[21]  C. Christiansen,et al.  Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women. , 1992, The Journal of clinical endocrinology and metabolism.

[22]  A. Hergenroeder,et al.  Bone mineral density in 15- to 21-year-old eumenorrheic and amenorrheic subjects. , 1992, American journal of diseases of children.

[23]  D. Clements,et al.  Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. , 1992, Scandinavian journal of gastroenterology.

[24]  W. Goodman,et al.  Changes in vertebral bone density in black girls and white girls during childhood and puberty. , 1991, The New England journal of medicine.

[25]  N. Bell,et al.  Demonstration that bone mass is greater in black than in white children , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  D. Mccormick,et al.  Spinal bone mineral density in 335 normal and obese children and adolescents: Evidence for ethnic and sex differences , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  M. Capobianchi,et al.  Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers. , 1991, Gut.

[28]  P. Delmas,et al.  Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters. , 1990, The Journal of clinical endocrinology and metabolism.

[29]  C. Langman,et al.  Abnormalities in serum osteocalcin values in children with chronic rheumatic diseases. , 1990, The Journal of pediatrics.

[30]  B. Kirschner.  Growth and Development in Chronic Inflammatory Bowel Disease , 1990, Acta paediatrica Scandinavica. Supplement.

[31]  S. Hodgson.  Corticosteroid-induced osteoporosis. , 1990, Endocrinology and metabolism clinics of North America.

[32]  L. Raisz,et al.  Glucocorticoid-induced osteoporosis: pathogenesis and management. , 1990, Annals of internal medicine.

[33]  J. Compston,et al.  Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. , 1988, Gut.

[34]  B. Kirschner.  Nutritional consequences of inflammatory bowel disease on growth. , 1988, Journal of the American College of Nutrition.

[35]  R. Hällgren,et al.  The acute effect of high dose corticosteroid treatment on serum osteocalcin. , 1988, Metabolism: clinical and experimental.

[36]  F. Dewhirst,et al.  Interleukin‐1β is a potent inhibitor of bone formation in vitro , 1987 .

[37]  E. Canalis.  Effects of tumor necrosis factor on bone formation in vitro. , 1987, Endocrinology.

[38]  J. Compston,et al.  Osteoporosis in patients with inflammatory bowel disease. , 1987, Gut.

[39]  P. Hodges,et al.  Disorders of Mineral and Bone Metabolism in Patients with Crohn's Disease , 1987 .

[40]  B. Lukert,et al.  Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids. , 1986, The Journal of clinical endocrinology and metabolism.

[41]  D. Cole,et al.  Serum osteocalcin concentrations in children with metabolic bone disease. , 1985, The Journal of pediatrics.

[42]  J. Lian,et al.  Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting. , 1984, The Journal of clinical endocrinology and metabolism.

[43]  R. Horst,et al.  A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies. , 1984, The Journal of clinical endocrinology and metabolism.

[44]  L. Deftos,et al.  New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. , 1980, The Journal of clinical investigation.

[45]  C. Christiansen,et al.  Effect of puberty on rates of bone growth and mineralisation: with observations in male delayed puberty. , 1979, Archives of disease in childhood.